Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9538129rdf:typepubmed:Citationlld:pubmed
pubmed-article:9538129lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:9538129lifeskim:mentionsumls-concept:C0699791lld:lifeskim
pubmed-article:9538129lifeskim:mentionsumls-concept:C0332307lld:lifeskim
pubmed-article:9538129lifeskim:mentionsumls-concept:C0026882lld:lifeskim
pubmed-article:9538129lifeskim:mentionsumls-concept:C0040690lld:lifeskim
pubmed-article:9538129lifeskim:mentionsumls-concept:C0441471lld:lifeskim
pubmed-article:9538129lifeskim:mentionsumls-concept:C0205422lld:lifeskim
pubmed-article:9538129lifeskim:mentionsumls-concept:C1335671lld:lifeskim
pubmed-article:9538129lifeskim:mentionsumls-concept:C0522498lld:lifeskim
pubmed-article:9538129pubmed:issue5lld:pubmed
pubmed-article:9538129pubmed:dateCreated1998-6-2lld:pubmed
pubmed-article:9538129pubmed:abstractTextMutations of the transforming growth factor-beta type II receptor (TGF-beta RII) gene have been detected in several human cancers. However, mutation analysis of coding sequences of TGF-beta RII in gastric carcinomas has not yet been fully elucidated. We performed PCR-SSCP analysis and direct DNA sequencing of the entire coding region of TGF- RII in 38 human sporadic gastric cancers and 8 gastric cancer cell lines. Mutations of the TGF-beta RII were detected in two tumors and three cell lines. Two tumors had one base deletion in the polyadenine tract in exon 3, the cystein-rich extracellular domain. Three cell lines had a silent mutation in the kinase domain located in exon 4. Polymorphisms were detected in introns 2 and 3. An a/g polymorphism was observed at the seventh base in intron 2 and an a/t polymorphism was observed at the fourth to last base in intron 3. There were no mutations in exons 1, 2, 5, 6 and 7. These results indicate that the polyadenine tract in the TGF-beta RII is a mutational hot spot in human gastric cancer. However, these results also suggest that mutations of the gene are rare events in human sporadic gastric cancer.lld:pubmed
pubmed-article:9538129pubmed:languageenglld:pubmed
pubmed-article:9538129pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9538129pubmed:citationSubsetIMlld:pubmed
pubmed-article:9538129pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9538129pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9538129pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9538129pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9538129pubmed:statusMEDLINElld:pubmed
pubmed-article:9538129pubmed:monthMaylld:pubmed
pubmed-article:9538129pubmed:issn1019-6439lld:pubmed
pubmed-article:9538129pubmed:authorpubmed-author:NagamachiYYlld:pubmed
pubmed-article:9538129pubmed:authorpubmed-author:TaharaEElld:pubmed
pubmed-article:9538129pubmed:authorpubmed-author:TakenoshitaSSlld:pubmed
pubmed-article:9538129pubmed:authorpubmed-author:YasueSSlld:pubmed
pubmed-article:9538129pubmed:authorpubmed-author:YokozakiHHlld:pubmed
pubmed-article:9538129pubmed:authorpubmed-author:ShitaraYYlld:pubmed
pubmed-article:9538129pubmed:issnTypePrintlld:pubmed
pubmed-article:9538129pubmed:volume12lld:pubmed
pubmed-article:9538129pubmed:ownerNLMlld:pubmed
pubmed-article:9538129pubmed:authorsCompleteYlld:pubmed
pubmed-article:9538129pubmed:pagination1061-5lld:pubmed
pubmed-article:9538129pubmed:dateRevised2008-11-21lld:pubmed
pubmed-article:9538129pubmed:meshHeadingpubmed-meshheading:9538129-...lld:pubmed
pubmed-article:9538129pubmed:meshHeadingpubmed-meshheading:9538129-...lld:pubmed
pubmed-article:9538129pubmed:meshHeadingpubmed-meshheading:9538129-...lld:pubmed
pubmed-article:9538129pubmed:meshHeadingpubmed-meshheading:9538129-...lld:pubmed
pubmed-article:9538129pubmed:meshHeadingpubmed-meshheading:9538129-...lld:pubmed
pubmed-article:9538129pubmed:meshHeadingpubmed-meshheading:9538129-...lld:pubmed
pubmed-article:9538129pubmed:meshHeadingpubmed-meshheading:9538129-...lld:pubmed
pubmed-article:9538129pubmed:meshHeadingpubmed-meshheading:9538129-...lld:pubmed
pubmed-article:9538129pubmed:meshHeadingpubmed-meshheading:9538129-...lld:pubmed
pubmed-article:9538129pubmed:meshHeadingpubmed-meshheading:9538129-...lld:pubmed
pubmed-article:9538129pubmed:meshHeadingpubmed-meshheading:9538129-...lld:pubmed
pubmed-article:9538129pubmed:meshHeadingpubmed-meshheading:9538129-...lld:pubmed
pubmed-article:9538129pubmed:meshHeadingpubmed-meshheading:9538129-...lld:pubmed
pubmed-article:9538129pubmed:meshHeadingpubmed-meshheading:9538129-...lld:pubmed
pubmed-article:9538129pubmed:year1998lld:pubmed
pubmed-article:9538129pubmed:articleTitleMutation of the transforming growth factor-beta type II receptor gene is a rare event in human sporadic gastric carcinomas.lld:pubmed
pubmed-article:9538129pubmed:affiliationFirst Department of Pathology, Hiroshima University School of Medicine, Hiroshima 734-8551, Japan.lld:pubmed
pubmed-article:9538129pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9538129pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9538129lld:pubmed